NEW YORK (Reuters Health) – Cancer of the back of the mouth and throat is on the rise, primarily because of more cases stemming from

A combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine a form of head and neck cancer (HNC) that

Tobacco companies knew for more than four decades that cigarette smoke contained radioactive alpha particles, and the firms developed “deep and intimate” knowledge of these

An ongoing research study of Access Pharmaceuticals’ MuGard mucoadhesive oral wound rinse has found that it is effective in prevention, delay, and management of radiotherapy-

A federal judge expressed doubts during a hearing last week about whether the U.S. Food and Drug Administration (FDA) can force tobacco companies to post

Antinerve growth factor could be used to enhance the treatment of oral cancer by reducing symptoms such as pain and rapid weight loss, according to

Researchers from Louisiana State University (LSU) are collaborating with the University of Chicago and 13 other research institutions to evaluate an immunosuppressant drug’s potential to

Combining the drug cetuximab with poly ADP-ribose polymerase (PARP) inhibitors may improve outcomes in head and neck cancer patients by preventing the cancer cells from

A preliminary study suggests that a magnetic resonance imaging (MRI) technique called SWIFT (sweep imaging with Fourier transform) can provide a 3Dl assessment that may

Why are African-Americans more likely than Caucasians not only to be diagnosed with head and neck cancer, but also to die from the disease? While

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to